Antibody responses to BNT162b2 mRNA COVID-19 vaccine in 2,015 healthcare workers in a single tertiary referral hospital in Japan

Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka, Toshibumi Taniguchi, Hidetoshi Igari, Yoshihiro Onouchi, Atsushi Kaneda, Kazuyuki Matsushita, Hideki Hanaoka, Taka-Aki Nakada, Seiji Ohtori, Ichiro Yoshino, Hisahiro Matsubara, Toshinori Nakayama, Koutaro Yokote, Hiroshi Nakajima
doi: https://doi.org/10.1101/2021.06.01.21258188

Article Information

doi 
https://doi.org/10.1101/2021.06.01.21258188
History 
  • June 4, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Takahiro Kageyama1,*,
  2. Kei Ikeda1,*,
  3. Shigeru Tanaka1,*,
  4. Toshibumi Taniguchi2,
  5. Hidetoshi Igari2,
  6. Yoshihiro Onouchi3,
  7. Atsushi Kaneda4,
  8. Kazuyuki Matsushita5,
  9. Hideki Hanaoka6,
  10. Taka-Aki Nakada7,
  11. Seiji Ohtori8,
  12. Ichiro Yoshino9,
  13. Hisahiro Matsubara10,
  14. Toshinori Nakayama11,
  15. Koutaro Yokote12 and
  16. Hiroshi Nakajima1,†
  1. 1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  2. 2Department of Infectious Diseases, Chiba University Hospital, Graduate School of Medicine, Chiba University, Chiba, Japan
  3. 3Department of Public Health, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  4. 4Department of Molecular Oncology, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  5. 5Division of Laboratory Medicine, Chiba University Hospital, Graduate School of Medicine, Chiba University, Chiba, Japan
  6. 6Clinical Research Centre, Chiba University Hospital, Graduate School of Medicine, Chiba University, Chiba, Japan
  7. 7Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  8. 8Department of Orthopaedic Surgery, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  9. 9Department of General Thoracic Surgery, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  10. 10Department of Frontier Surgery, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  11. 11Department of Immunology, Graduate School of Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  12. 12Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan
  1. ↵†Corresponding Author
    Hiroshi Nakajima, Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba 260-8670, Japan. Fax number: +81-43-226-2199, Telephone number: +81-43-226-2198, E-mail: nakajimh{at}faculty.chiba-u.jp.
Back to top
Posted June 04, 2021.
Download PDF
Data/Code
Email
Antibody responses to BNT162b2 mRNA COVID-19 vaccine in 2,015 healthcare workers in a single tertiary referral hospital in Japan
Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka, Toshibumi Taniguchi, Hidetoshi Igari, Yoshihiro Onouchi, Atsushi Kaneda, Kazuyuki Matsushita, Hideki Hanaoka, Taka-Aki Nakada, Seiji Ohtori, Ichiro Yoshino, Hisahiro Matsubara, Toshinori Nakayama, Koutaro Yokote, Hiroshi Nakajima
medRxiv 2021.06.01.21258188; doi: https://doi.org/10.1101/2021.06.01.21258188
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area